4
Changes in Ownership
RHYTHM PHARMACEUTICALS, INC. Filed Acc 0001649904-26-000023
Chief Financial Officer sold 62,774 shares at an average $105.46 ($6,619,913)
- Chief Financial Officer acquired 57,187 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Smith Hunter C Chief Financial Officer | 2026-08-31 | Option exercise 10b5-1 | +57,187 | $25.79 | $1,474,853 | 176,798 | D: show line 1 in the form |
| Smith Hunter C Chief Financial Officer | 2026-08-31 | Sale 10b5-1 | −23,072 | $104.59 | $2,413,034 | 153,726 | D: show line 2 in the form |
| Smith Hunter C Chief Financial Officer | 2026-08-31 | Sale 10b5-1 | −11,514 | $105.37 | $1,213,232 | 142,212 | D: show line 3 in the form |
| Smith Hunter C Chief Financial Officer | 2026-08-31 | Sale 10b5-1 | −28,188 | $106.20 | $2,993,647 | 114,024 | D: show line 4 in the form |
| Open-market sales · 62,774 sh · avg $105.46 · $6,619,913 | |||||||
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| Smith Hunter C Chief Financial Officer | 2026-08-31 | Option exercise · Employee Stock Option (Right to Buy) 10b5-1 | −57,187 | 3,813 | D: show line 5 in the form |
Loading xslF345X06/form4.xml…